We thus wanted to evaluate whether the modulatory effects of MSUT2 KO on tau pathogenesis that was observed upon AD-tau seeding would also be seen after seeding with pathologic tau isolated from other subtypes of tauopathies. This evidence concerns the gene MAPT and Alzheimer disease.